Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV treatment adherence, drug resistance, virologic failure: evolving concepts.
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, Mills EJ, Gross R. Nachega JB, et al. Among authors: marconi vc. Infect Disord Drug Targets. 2011 Apr;11(2):167-74. doi: 10.2174/187152611795589663. Infect Disord Drug Targets. 2011. PMID: 21406048 Free PMC article. Review.
Second-line antiretroviral therapy: long-term outcomes in South Africa.
Murphy RA, Sunpath H, Castilla C, Ebrahim S, Court R, Nguyen H, Kuritzkes D, Marconi VC, Nachega JB. Murphy RA, et al. Among authors: marconi vc. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):158-163. doi: 10.1097/QAI.0b013e3182615ad1. J Acquir Immune Defic Syndr. 2012. PMID: 22692090 Free PMC article.
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Tang MW, et al. Among authors: marconi vc. J Infect Dis. 2013 Jun 15;207 Suppl 2(Suppl 2):S70-7. doi: 10.1093/infdis/jit114. J Infect Dis. 2013. PMID: 23687292 Free PMC article.
Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.
Marconi VC, Wu B, Hampton J, Ordóñez CE, Johnson BA, Singh D, John S, Gordon M, Hare A, Murphy R, Nachega J, Kuritzkes DR, del Rio C, Sunpath H; South Africa Resistance Cohort Study Team Group Authors. Marconi VC, et al. AIDS Patient Care STDS. 2013 Dec;27(12):657-68. doi: 10.1089/apc.2013.0263. AIDS Patient Care STDS. 2013. PMID: 24320011 Free PMC article.
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.
Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK. Gregson J, et al. Among authors: marconi vc. Lancet Infect Dis. 2017 Mar;17(3):296-304. doi: 10.1016/S1473-3099(16)30469-8. Epub 2016 Dec 1. Lancet Infect Dis. 2017. PMID: 27914856 Free PMC article.
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.
Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW. Rhee SY, et al. Among authors: marconi vc. EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024. Epub 2017 Mar 19. EBioMedicine. 2017. PMID: 28365230 Free PMC article.
Management of Virologic Failure and HIV Drug Resistance.
McCluskey SM, Siedner MJ, Marconi VC. McCluskey SM, et al. Among authors: marconi vc. Infect Dis Clin North Am. 2019 Sep;33(3):707-742. doi: 10.1016/j.idc.2019.05.004. Epub 2019 Jun 27. Infect Dis Clin North Am. 2019. PMID: 31255384 Free PMC article. Review.
Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005-2015.
Davy-Mendez T, Napravnik S, Hogan BC, Althoff KN, Gebo KA, Moore RD, Horberg MA, Silverberg MJ, Gill MJ, Crane HM, Marconi VC, Bosch RJ, Colasanti JA, Sterling TR, Mathews WC, Mayor AM, Nanditha NGA, Buchacz K, Li J, Rebeiro PF, Thorne JE, Nijhawan A, van Duin D, Wohl DA, Eron JJ, Berry SA; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Davy-Mendez T, et al. Among authors: marconi vc. J Infect Dis. 2021 Jun 15;223(12):2113-2123. doi: 10.1093/infdis/jiaa661. J Infect Dis. 2021. PMID: 33084891 Free PMC article.
300 results